Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
WisdomTree BioRevolution Fund (WDNA) belongs to the BioTech & Genomics segment. Tema Oncology ETF (CANC) is part of the Tomorrow's Treatments segment. WDNA's top 3 sector exposures are Health Care, Materials and Consumer Staples. In contrast, CANC's top sector exposures are Health Care, WDNA is less expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.99% for CANC. WDNA is up 4.96% year-to-date (YTD) with -$357K in YTD flows. CANC performs better with 7.12% YTD performance, and +$41M in YTD flows. Run a side-by-side ETF comparison of WDNA and CANC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | WDNA CANC | -0.46%+1.48% | +4.60%+7.25% | +4.96%+7.12% | +38.09%+50.21% | +12.49%n/a | n/an/a |
| Flows | WDNA CANC | -$357K+$12M | -$357K+$51M | -$357K+$41M | -$357K+$63M | -$524K- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | WDNA CANC | +22.81%+22.49% | +28.57%+24.99% | +24.57%n/a | n/an/a |
| Max drawdown | WDNA CANC | -8.60%-4.64% | -17.47%-17.26% | -37.80%n/a | n/an/a |
| Max drawdown duration | WDNA CANC | 48d29d | 106d80d | 901dn/a | n/an/a |
WDNA | CANC | |
Last sale 3/12/2026 at 1:30 PM | $17.25 | $36.33 |
| Previous close 03/11/2026 | $17.67 | $37.16 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
WDNA | CANC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
WDNA | CANC | |
|---|---|---|
| Last price | $17.25 | $36.33 |
| 1D performance | -2.35% | -2.23% |
| AuM | $2.31 M | $165.84 M |
| E/R | 0.45% | 0.99% |
WDNA | CANC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | WisdomTree | Tema |
| Benchmark | WisdomTree BioRevolution Index | - |
| N° of holdings | 75 | 46 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 3, 2021 | August 15, 2023 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
